Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer’s Disease
Acetylcholinesterase (AChE) catalyzes the hydrolysis of neurotransmitter acetylcholine to acetate and choline in a synaptic cleft. Deficits in cholinergic neurotransmitters are linked closely with the progression of Alzheimer’s disease (AD), which is a neurodegenerative disorder characteri...
Main Authors: | Minky Son, Chanin Park, Shailima Rampogu, Amir Zeb, Keun Woo Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/4/1000 |
Similar Items
-
Discovery of Potential Plant-Derived Peptide Deformylase (PDF) Inhibitors for Multidrug-Resistant Bacteria Using Computational Studies
by: Shailima Rampogu, et al.
Published: (2018-12-01) -
In Silico Study Probes Potential Inhibitors of Human Dihydrofolate Reductase for Cancer Therapeutics
by: Rabia Mukhtar Rana, et al.
Published: (2019-02-01) -
Identification of the most potent acetylcholinesterase inhibitors from plants for possible treatment of Alzheimer’s disease: a computational approach
by: Bishajit Sarkar, et al.
Published: (2021-02-01) -
Structure Based Design and Molecular Docking Studies for Phosphorylated Tau Inhibitors in Alzheimer’s Disease
by: Jangampalli Adi Pradeepkiran, et al.
Published: (2019-03-01) -
Molecular docking study of the acetylcholinesterase inhibition
by: Merzoug Amina, et al.
Published: (2021-03-01)